CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 4 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $373,893 | +61.1% | 31,984 | +85.2% | 0.01% | +55.6% |
Q2 2023 | $232,096 | -91.1% | 17,269 | -89.0% | 0.01% | -91.7% |
Q1 2023 | $2,598,451 | +76.1% | 156,722 | +97.6% | 0.11% | +38.5% |
Q4 2022 | $1,475,519 | +142.3% | 79,329 | +67.0% | 0.08% | +225.0% |
Q3 2022 | $609,000 | +6.1% | 47,500 | -42.0% | 0.02% | -4.0% |
Q2 2022 | $574,000 | -33.1% | 81,901 | -20.9% | 0.02% | -32.4% |
Q1 2022 | $858,000 | +3.5% | 103,494 | -15.4% | 0.04% | -28.8% |
Q4 2021 | $829,000 | +278.5% | 122,400 | +222.2% | 0.05% | +147.6% |
Q2 2021 | $219,000 | -13.8% | 37,983 | -31.1% | 0.02% | -12.5% |
Q1 2021 | $254,000 | +62.8% | 55,100 | +5.0% | 0.02% | -22.6% |
Q3 2020 | $156,000 | – | 52,500 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
XML Financial, LLC | 40,000 | $119,000 | 0.04% |